Showing results (151-160 of 168) with videos related to
Sort By:
Pageof 17
Science Advances|July 19, 2024
Targeting conserved TIM3<sup>+</sup>VISTA<sup>+</sup> tumor-associated macrophages overcomes resistance to cancer immunotherapyIsaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, et al.ACS Medicinal Chemistry Letters|April 20, 2018
Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs DiscoveryDongwei Kang, Zhao Wang, Heng Zhang, et al.Nature Communications|October 2, 2024
Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancerVincent de Laat, Halit Topal, Xander Spotbeen, et al.Nature Genetics|March 9, 2021
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2Jim Baggen, Leentje Persoons, Els Vanstreels, et al.The Journal of Allergy and Clinical Immunology|June 22, 2025
Inhibition of lysosomal degradation increases expression of mutant ADA2 in DADA2 monocytesLisa Ehlers, Marjon Wouters, Bethany Pillay, et al.Frontiers in Immunology|July 4, 2024
IL-10 predicts incident neuroinflammatory disease and proviral load dynamics in a large Brazilian cohort of people living with human T-lymphotropic virus type 1Tatiane Assone, Soraya Maria Menezes, Fernanda de Toledo Gonçalves, et al.Blood|October 5, 2012
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemiaRosa Lapalombella, Qingxiang Sun, Katie Williams, et al.European Journal of Medicinal Chemistry|June 12, 2021
Benzofuranyl-2-imidazoles as imidazoline I<sub>2</sub> receptor ligands for Alzheimer's diseaseSergio Rodriguez-Arévalo, Andrea Bagán, Christian Griñán-Ferré, et al.Journal of Neuroinflammation|December 9, 2022
Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammationTatiane Assone, Soraya Maria Menezes, Fernanda de Toledo Gonçalves, et al.Nature|September 30, 2016
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancerJimi Kim, Elizabeth McMillan, Hyun Seok Kim, et al.Pageof 17